CANCER DRIVER INTERCEPTION, Systemic Inflammation, Gut Dysbiosis, Genomic Instability, Immune System Deficiency, PRENATAL SCREENING, G-TEST, ULTRANIPT , ULTRANIPT DG, OMNIPT, Inherited Metabolic Disorder, Severe Combined Immunodeficiency, Lysosomal Storage Diseases, CANCER EARLY DETECTION, Solid Cancer, Breast and Ovary, Lung, Colon and rectum, Genome Instability, AESTHETICS STEM CELLS, Skin Rejuvenation, Face Reshaping, Breast augmentation, Buttock enhancement, Scar Reduction, Hair Loss, Female rejuvenation, Penis enlargment, HEREDITARY CANCERS DRIVERS, Endometrium, Colon, Solid Cancers, Breast and Ovary, REGENERATIVE STEM CELLS, Orthopedics, Premature Ovarian Failure, Erectile dysfunction, Anti-aging Therapy iV, Empty Nose Syndrome, Body Performance, Supportive Care, CANCER DIAGNOSIS, Colon and Rectum, Breast, Ovary and Prostate, Lung Cancer Assay, Liquid Biopsy, STEM CELL EXOSOMES, Skin Aging, Hair Loss, Orthopedics, Erectile Dysfunction, Female Rejuvenation, Body Performance, Anti-Ageing, PREVENTIVE CANCER THERAPY, Systemic Inflammation, Dysbiosis, Genomic Instability, Immune Deficiency, STEM CELL BANKING, Cord Blood Derived, Cord Tissue Derived, Adipose Tissue Derived, EXOSOME COSMETICS, X-FILL – Eye & Lip Contour, X-LIFT – Firm Facial Lifting, X-SKIN- Advanced Moisturizing, X-HAIR – Hair Loss Treatment

IMMUNEDRIVE

Food supplement with vitamins C and D and Withania
30 capsules | Net content 19.80 g

Description

IMMUNEDRIVE is a food supplement designed to support the immune system and fight inflammation through a blend of vitamin D, vitamin C, enzymes and natural extracts with anti-inflammatory properties and able to promote the body’s natural defenses.

Vitamin D contributes to the normal functioning of the immune system and is associated with normal inflammatory responses1. Two capsules of IMMUNEDRIVE provide a dose of vitamin D corresponding to 1000% of the nutrient reference values (NRVs), equal to 5 mcg2.

Acerola fruits are recognized as having a supportive and tonic action and the ability to promote the body’s natural defenses. They are also antioxidants3. The vitamin C present in them contributes to the normal functioning of the immune system and the reduction of tiredness and fatigue1.

Withania root also promotes the body’s natural defenses. Considered a tonic-adaptogen, it is recommended in case of physical and mental tiredness3.

Scientific studies have associated the Ash with anti-inflammatory, antioxidant and anticancer properties4.

Enzi-mix® is an enzymatic complex (Amylase, Protease, Glucoamylase, Lipase, Cellulase, Lactase, Pectinase) from fermented vegetable substrates.

Ingredients: Acerola (Malpighia glabra L.) fruit d.e. (25% Vitamin C), maltodextrin, hydroxypropyl methylcellulose (capsule shell), Enzymatic complexes from fermented vegetable substrates Enzi-mix® (Amylase, Protease, Glucoamylase, Lipase, Cellulase, Lactase, Pectinase), Ash (Fraxinus excelsior L .) leaves d.e. (2% Chlorogenic acid), Withania (Withania somnifera (L.) Dunal) root d.e. (2.5% Withanolides), Vitamin D2 (Ergocalciferol), anti-caking agents: silicon dioxide, magnesium salts of fatty acids.

Average contents Daily dose (2 capsules)
Acerola fruit d.e.
of which Vitamin C
3200 mg
80 mg (100% VNR)
Enzymatic complexes from Enzi-mix® fermented vegetable substrates 200 mg
Ash leaves d.e.
of which Chlorogenic acid
150 mg
3 mg
Withania root d.e.
of which Withanolides
100 mg
2,5 mg
Vitamin D 0.05 mg ˜ 2000 UI (1000% VNR)

*bln CFU = billion Colony Forming Units

Distributed by Bioscience Institute SpA – Strada Rovereta, 42 – 47891 Falciano (RSM)

  1. EU Register of Health Claims. ec.europa.eu. 24/01/23
  2. Regolamento (UE) 1169/2011. Allegato XIII
  3. Ministero della Salute. Allegato 1 al DM 10 agosto 2018 sulla disciplina dell’impiego negli integratori alimentari di Sostanze e preparati vegetali come aggiornato con Decreto 9 gennaio 2019 e linee guida ministeriali di riferimento per gli effetti fisiologici
  4. Iqra Sarfraz I et al. Fraxinus: A Plant with Versatile Pharmacological and Biological Activities. Evid Based Complement Alternat Med. 2017; 2017: 4269868. doi: 10.1155/2017/4269868
×

Information Request








    Privacy Policy (*)